Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay Probe, DNA, 16, EA
The Agilent SureSelect Tumor Map Assay Probe, DNA (16 reactions) is designed for use in targeted next-generation sequencing (NGS) applications, enabling comprehensive analysis of tumor DNA. This assay utilizes Agilent's SureSelect technology to provide high specificity and sensitivity for detecting genetic alterations in tumor samples. The kit includes DNA probes optimized for hybrid capture, facilitating efficient enrichment of target regions from complex genomic DNA. It is suitable for use in cancer research and molecular diagnostics, supporting accurate variant detection and tumor profiling workflows.